Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Prezista 100mg/ml oral suspension
0503010ACBBAFAF
|
Prezista | Darunavir | Infections | No data available |
|
Prezista 150mg tablets
0503010ACBBAEAE
|
Prezista | Darunavir | Infections | No data available |
|
Prezista 300mg tablets
0503010ACBBAAAA
|
Prezista | Darunavir | Infections | No data available |
|
Prezista 400mg tablets
0503010ACBBABAB
|
Prezista | Darunavir | Infections | No data available |
|
Prezista 600mg tablets
0503010ACBBACAC
|
Prezista | Darunavir | Infections | No data available |
|
Prezista 75mg tablets
0503010ACBBADAD
|
Prezista | Darunavir | Infections | No data available |
|
Prezista 800mg tablets
0503010ACBBAGAG
|
Prezista | Darunavir | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.